Skip to main content
. 2000 Apr;49(4):323–330. doi: 10.1046/j.1365-2125.2000.00164.x

Table 1.

Serum pharmacokinetic variables following oral mesalazine dosing.

Oral dose 1.2 g day−1 2.4 g day−1 4.8 g day−1
Cmax (µg ml−1) 5ASA 1.1(0.1- 8.6) *3.3(0.4-9.2) *6.0(1.4-4.2)
NA5ASA 2.2(1.4–8.7) 4.0(0.8–8.5) *5.9(1.8–10.6)
Cmin (µg ml−1) 5ASA 0.03(0-0.2) *0.2(0.03–1.1) *1.3(0.4–2.8)
NA5ASA 0.4(0.1–1.0) *0.8(0.3–2.2) *2.2(1–3.9)
AUC (µg ml−1 h) 5ASA 3.9(0.6–4.3) *15.4(2.5–66) *47(8.5–139)
NA5ASA 17.2(7–64) *31(6–84) *58(17–117)

All values expressed as median (range).

*

denotes significant (P < 0.05) between dose differences.